in epilepsy genetics and the development of novel disease models, drug screening technologies and innovative therapeutic modalities over the past 10 years, more than 200 novel epilepsy therapies are currently in the preclinical or clinical pipeline, including many treatments that act by new mechanisms....
New epilepsy treatmentsThe article offers information on the suggested epilepsy treatments from the National Institute for Health and Clinical Excellence (NICE) of Great Britain which include buccal midazolam, rectal diazepam, and intravenous lorazepam.Pulse...
For more than 30 years, we have provided solutions that have helped transform the epilepsy landscape and improved the lives of millions of people. Our scientists have developed several life-changing solutions, providing individualized treatments to help people living with epilepsy.Utilizing...
conference, we will be continuing with debates as well as adhering to the format of the previous conferences which are designed to provide an in-depth progress report on new antiepileptic drugs in various stages of development, as well as to present new findings on second-generation treatments. ...
The new treatment, named the Mental Health Intervention for Children with Epilepsy (MICE), is based on the treatments that the National Institute for Health and Care Excellence (NICE) recommends for the treatment of common mental health difficulties, likecognitive behavioral therapyfor anxiety and dep...
In conclusion, several new promising routes are being developed to ameliorate existing therapies for CDS, and to find new treatments for the so far challenging CTD (Table 3). These new strategies may involve the use of the nose-to-brain delivery, pharmacochaperones as well as gene therapy thro...
The new system was implemented as part of the AURORA study by the medical technology manufacturer Synergia Medical. According to CEO and co-founder Attila Borbáth, the system could facilitate the precision of future treatments and minimise the invasion of medical procedures for patients. ...
He adds that the development of molecular biology with targeted treatments of the rheumatic disorders would be a great assistance for rheumatologists.关键词: Humans Rheumatic Diseases Inflammation DOI: 10.1186/1471-2474-10-79 被引量: 8 年份: 2009 ...
Panelists discuss how recent data presented at the 2024 American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM) conference may impact clinical practice for myasthenia gravis, highlighting emerging treatments they find particularly promising for future management of the condition. ...
Brussels, Belgium – Monday 9th September 2024 – 7:00 CEST– The need for quicker and more accurate Lennox-Gastaut syndrome (LGS) diagnoses was highlighted today in a European real-world study presented at the 15th European Epilepsy Congres...